Deciphera Pharmaceuticals Inc expected to post a loss of $1.33 a share - Earnings Preview

Deciphera Pharmaceuticals

05/02/2022 02:04

* Deciphera Pharmaceuticals Inc  DCPH.OQ   DCPH.O  is
expected
to show a rise in quarterly revenue when it reports  results on
February 8. 
    * The Waltham Massachusetts-based  company is expected to
report 
a 19.5% increase in revenue to $23.29 million from $19.49
million a year ago, according to the mean estimate from 11
analysts, based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Deciphera
Pharmaceuticals
Inc is for a loss of $1.33 per share. For the same quarter last
year, the company reported a loss of $1.10 per share.
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 7
"hold" and 1 "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Deciphera
Pharmaceuticals Inc is $11​, about 27.5% above​ its last closing
price of $7.97. ​​​
    * 

This summary was machine generated February 5 at 02:04 GMT.  All
figures in US dollars  unless otherwise stated